You're using an outdated browser. To get the most out of this website, as well as many others, please consider upgrading to a modern browser, such as Google Chrome, Mozilla Firefox, or Microsoft Edge.

Open menu


Cardiff University begins study of schizophrenia therapy

A new schizophrenia drug being developed by Cardiff University’s Medicines Discovery Institute (MDI) has completed the first phase of a phase 1 clinical trial.